Patient partnership in cardiovascular clinical trials.
Clinical trials
Drug development
Heart disease
Patient partner
Patient-centred care
Patient-oriented research
Patient-reported outcomes
Journal
European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263
Informations de publication
Date de publication:
06 04 2022
06 04 2022
Historique:
received:
06
08
2021
revised:
18
10
2021
accepted:
22
11
2021
pubmed:
14
12
2021
medline:
9
4
2022
entrez:
13
12
2021
Statut:
ppublish
Résumé
Patients are ultimately the end-users of medical therapies and need to be actively integrated as contributors and decision-makers in the process of product development throughout product lifecycles. This is increasingly being recognized by patients, investigators, regulators, payers, sponsors, and medical journals. However, cardiovascular research remains behind other fields in terms of the extent of patient involvement and awareness of clinical trials in cardiovascular research. True patient partnerships in cardiovascular therapeutic development may permit more rapid recognition of unmet needs, ensure alignment of product development priorities with patient priorities, improve efficiency of trials (e.g. recruitment), and ensure outcomes of value to patients are being measured in trials (e.g. quality of life). This paper reviews ongoing initiatives and remaining opportunities to accomplish contributive patient involvement in cardiovascular clinical research.
Identifiants
pubmed: 34897413
pii: 6460258
doi: 10.1093/eurheartj/ehab835
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1432-1437Informations de copyright
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.